KEDRON WALSH: Open Payments
NPI 1508589599 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,633 in 72 payments from 18 companies in 2025. Trend: 2023 $877 · 2024 $1,082 · 2025 $1,633
Food & beverage: $1,614Education: $19
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $355 |
| ABBVIE INC. | 15 | $284 |
| AstraZeneca Pharmaceuticals LP | 1 | $160 |
| Phathom Pharmaceuticals, Inc. | 4 | $157 |
| Novo Nordisk Inc | 7 | $153 |
| Lilly USA, LLC | 7 | $126 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| Amgen Inc. | 2 | $33 |
| Exact Sciences Corporation | 2 | $32 |
Products named: NURTEC ODT, QULIPTA, FARXIGA, VOQUEZNA, MOUNJARO, ZAVZPRET, Ozempic, LEQVIO.
Industry payments across VA — which companies pay providers there.
